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Abstract 
While historical screening efforts on drug discovery have largely focused on small molecule 
constituents of natural products, the antimicrobial drugs made from these small molecules have cultivated 
resistance in many microorganisms. Recent studies have shown that ribosomally-synthesized, post-
translationally-modified peptide natural products (RiPPs) have the potential to address this urgent need for 
new therapeutic compounds due to their target specificity, high potency and metabolic stability. While these 
bioactive RiPPs are ubiquitously expressed in natural products, plants are a promising and largely 
unexplored source for these peptides. To expedite the search for novel bioactive peptides, the PepSAVI-
MS pipeline was developed in the Hicks Lab. This pipeline begins with zero knowledge about the peptide 
profile of the species, but employs mass spectrometry and statistics to quickly determine the most-likely 
bioactive peptide targets. In this paper, Houttuynia cordata (chameleon plant) is subjected to PepSAVI-MS. 
Our data showed that fractions of its peptide library exhibit strong bioactivity against Escherichia coli, as 
well as the multi-drug resistant pathogens Acinetobacter baumannii, Klebsiella pneumoniae, and 
Staphylococcus aureus (gram-positive). The putative antimicrobial peptide candidates were identified using 
a hybrid LC-MS/MS and statistical analysis-based approach. This paper will focus on the discovery and 
characterization of the peptide candidate that has the highest probability to possess antimicrobial property.  
 
Introduction 
The emergence of drug-resistant bacteria associated with nosocomial infections has put new drug 
development in urgency. Throughout the decades, antibiotics have been abused and misused in various 
fields such as clinic prescriptions and agricultural practice. Bacteria, by their evolutionary mechanism, have 
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rapidly developed genetic resistance to multiple traditional drugs including ampicillin, imipenem and β-
lactam antibiotics. The most notorious members of multi-drug resistant microorganisms, the ESKAPE 
pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa and Enterobacter species) are prevalent in lethal hospital infections 
and reported to be resistant to nearly all classes of current antibiotics. There is consequently an increasing 
interest in developing novel classes of antibiotics.1 
Today’s drug market is mostly occupied by small molecules (<500 Da) and proteins (>10 kDa). 
The high oral bioavailability of small molecule drugs makes them widely used, but their low target 
selectivity and decreasing effectiveness against target pathogens have limited their use.2 The protein-based 
drugs such as growth factors and engineered antibodies, on the other hand, exhibit high specificity due to 
the complexity of interactions with the target cells. One concerning shortcomings regarding the 
development of these drugs is that their large size and intricate structures result in low membrane 
permeability and metabolic stability. Filling the gap in between, peptide-based drugs maintain a high 
potency and selectivity while remaining relatively stable in a proper molecular size.3 As such, 
antimicrobially active RiPPs (AMPs) are now popular drug candidates. Previous research has shown that 
the AMPs are mostly positively charged and ubiquitously produced in organisms as a result of self-defense, 
but they are not yet thoroughly explored due to the lack of study on natural peptidomics.4 Today with much 
more advanced mass spectrometry technology, the chracterization of peptide and protein libraries in 
organisms are no longer elusive.  
Among various sources of antimicrobial peptides, AMPs from plants are considered ideal for 
academic research because plants are relatively easy to collect, fast to reproduce and their medicinal use 
rich in historical records. Surprisingly, while at least 25% of the modern medicines are derived from plants5, 
only a very small fraction of plants have been studied for AMPs.6 Developing efficient methodologies of 
identifying and extracting potential lead compounds in herbal sources is consequently of great interest to 
analytical and biological chemists. Inspired by work on artemisinin-based drugs7, this project seeks help 
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from historical and practical records of Traditional Chinese medicine (TCM) in selecting candidate plants. 
Most AMPs are soluble and stable in water4, and most medicinal herb prescriptions in TCM use water as 
solvent for delivery.8  Therefore the plants frequently used for antimicrobial purposes in TCM are a good 
starting point to look for these highly stable and positively charged AMPs. In fact, Areca catechu (Areca 
palm) and Tulipa gesneriana (garden tulip), which are historically used for antiphlogistic treatments, have 
already been found to contain AMPs.9-10 
The recently published work on the PepSAVI-MS (Statistically guided bioactive peptides 
prioritized via mass spectrometry) pipeline has provided an efficient way to identify and analyze AMPs in 
previously uncharacterized plant peptide libraries.11 Traditional approaches to solve this problem are labor 
intensive, low throughput, and often lead to replication of previously known molecules. PepSAVI-MS  
addresses many of the current challenges in the natural product discovery. Aiming specifically at positively 
charged molecules with a molecular weight of 1-10 kDa, this pipeline eliminates organic compounds and 
small molecules early in the extraction process. The LC-MS/MS analysis coupled with statistical modeling 
allows individual bioactive components to be identified within the complex mixture of plant extracts. While 
the entire process does not require previous knowledge of the genomic sequence or total peptide content, it 
singles out highly promising AMP candidates and provides primary structural information prior to the 
isolation of target peptides.   
In this paper, Houttuynia cordata (commonly known as chameleon plant) will be our plant of 
choice. It has long been used for various medical treatments in Asia.12 Aside from the anti-cancer and anti-
inflammatory potency of its oil and ethanol extract, the antibacterial activity of its water extract has also 
been revealed.13 Here we report our findings on AMPs in H. cordata using PepSAVI-MS, and an example 
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Experimental Section 
Source materials and growth conditions. Mature aerial tissue of wild Houttuynia cordata were 
harvested at the Mountain Gardens in Asheville, North Carolina. Tissues was immediately flash frozen 
using dry ice and ethanol, transported in dry ice, and stored at -80 ℃. 
Peptide library creation. The peptide library creation follows the exact protocols of extraction 
and HPLC fractionation in the published PepSAVI-MS pipeline.11 To briefly summarize, 100 g frozen 
tissue was ground under liquid nitrogen, extracted in 300 mL of 10% acetic acid with protease inhibitors, 
and stirred at 4 ℃. Stericup filtration (0.45 μm) was performed after centrifugation, and further exclusion 
of molecules greater than 30 kDa or smaller than 1 kDa was carried out using Millipore protein 
concentration filters and SpectrumLabs dialysis bags (5 mM ammonium formate, pH 2.7). The sample 
was then vacuum centrifuged to 4 mL. In the subsequent fractionation, the previously concentrated extract 
was subjected to a strong cation exchange (SCX) chromatography using a PolySulfoethyl A column and a 
linearly increasing salt gradient in acidic conditions. A total of 47 one-minute fractions were collected and 
desalted with water to 400 μL per fraction before bioactivity assay. The sample was stored at 4 ℃, or -
20 ℃ if not for prompt use. 
Bioactivity assays. The standard lab strain Escherichia coli 25922 was obtained from ATCC. The 
47-SCX fractions were each added to a microtiter well with the bacteria cultures synchronized at mid-log 
phase growth. Known antibiotics were also used as the positive control (100% activity) and water was the 
negative control (0% activity) in place of plant fraction. A total of 3 sets of identical experiments on the 
whole series of fractions were done on two sterile 96 well microtiter plates with 20% bacteria culture and 
20% peptide fraction in MH media (50 μL per well). After a 4-hour incubation at 37 ℃ with 325 rpm 
shaking speed, the number of living cells in each well was determined using the fluorescent dye resazurin. 




) × 100%). 
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LC-MS/MS. The SCX fractions were simultaneously subjected to our nano-LC-ESI-MS/MS 
platform which is composed of a nanoAcquity (Waters, Milford, MA) coupled to a TripleTOF5600 (AB 
Sciex, Framingham, MA). The loading procedure and instrumentation was as described in the PepSAVI-
MS pipeline. In brief, chameleon plant peptide library was loaded to the instrument with 10:20 dilution, 
acidified with formic acid and transferred to low-volume 96-well plates for the injection onto the trap 
column (NanoAcquity UPLC 2G-W/M Trap 5 μm Symmetry C18, 180 μm × 20 mm: Waters) and the 
analytical C18 column (10k PSI, 100 Å, 1.8 μm, 75 μm × 250 mm: Waters). The separation was done 
with a 30-min linear ramp at a flow rate of 0.3 μL/min. The MS was set to positive-ion and high-
sensitivity mode, and the MS survey spectrum is set to a mass range of 350-1600 Da in 250 ms. MS/MS 
data under collision-induced dissociation (CID) fragmentation mode was acquired using information-
dependent acquisition (IDA). The first 20 features with +2 to +5 charge state were fragmented using 
rolling collision energy (± 5%). Progenesis QI for proteomics software was used to obtain deisotoped 
peak list and to align runs based on the chosen fraction (fraction 19). The software gave the summed 
abundance of each of the 12078 identified MS features for the chameleon plant.  
Data Reduction and Statistical Modeling. The published PepSAVI-MS package in R allowed 
the reduction of MS features and the bioactivity probability analysis of these features. First, the binning 
function in PepSAVI-MS package assigned the peak-picked data within 0.05 Da error tolerance to the 
same MS feature. At the same time, it only picked features that were in 14 - 45 min retention time range, 
that were 1 – 15 kDa large and that bore a charge state between +2 and +10. Next, each bioactive region 
of the peptide library (termed as “area of interest”) was manually selected: E.coli (21-24), K. pneumoniae 
(16-25), A. baumannii (19-26), and S. aureus (19-26). Based on the input of bioactive region of interest, 
the filtering function finds the MS features that satisfied the following criteria: 1) m/z intensity maximum 
should be inside the “area of interest”; 2) this maximum intensity should be >1000; 3) its intensity at the 
boundaries should be <1% of the maximum peak intensity; 4) its intensity at the immediate neighboring 
fractions of the maximum peak should not be zero; 5) its charge state should be less than +10. The 
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selected features were then modeled using the elastic net estimator with a quadratic penalty parameter of 
specification of 0.001. The estimator assessed the possible contribution of each MS feature to the 
observed bioactivity and aligned them accordingly, and it also assigned each feature an individual 
correlation to the bioactivity trend.    
De novo Sequencing. Mass features that were of the highest probability to contribute to the 
antimicrobial activity were selected for downstream identification. The amino acid sequence of our target 
was predicted using the PEAKS Studio software (Bioinformatics Soluntions Inc) with a precursor neutral 
mass range of 1698.85-1698.89 and a MS2 data error tolerance of 0.1 Da. 
 
Results and Discussion 
Plant Selection, Cultivation, and Harvesting. Plant species (H. cordata) is chosen based on 
historical records of TCM, known bioactivity of its water extract, and availability. The leaves were obtained 
from H. cordata grown in the damp soil near a pond at the Mountain Gardens, NC. For scientific rigidity, 
the biological identity of the plant is expected to be verified by gene sequencing in future plans. 
Peptide Library Creation. Aqueous extraction is used to extract molecules soluble in water. Size 
exclusion techniques including high molecular weight cutoff filtration and dialysis are employed to confine 
the molecular size in 1-10 kDa. The crude extract is further separated into 1-min fractions using strong 
cation exchange chromatography, and the fractions are aligned by the order of charge strength. To minimize 
the effects of high salt content in bioactivity assays, the fractions are desalted using vacuum concentration. 
Bioactivity Assays. Whole-cell bioactivity screening was used to determine the relative killing 
efficiency of each SCX fraction against the chosen pathogens. Figure 1(a) demonstrates the calculated 
killing efficiency of each fraction against the lab standard E. coli strand. In reading the result, activity above 
30% is considered indicative of notable bioactivity due to the sensitivity of the assay. The first 10 fractions 
are most likely bioactive small molecules and the last 10 are most likely high-salt content inhibiting bacteria 
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growth. Therefore, our focus is narrowed to fractions 10-35 for bioactive peptides. The region of fractions 
21-24 displays a promising trend of bioactivity, corresponding to the concentration trend of the eluting 
bioactive peptide(s).  
 
Figure 1  Percent killing activity of Japanese honeysuckle against: a) Escherichia coli; b) Klebsiella 
pneumoniae; c) Acinetobacter baumannii; d) Staphylococcus aureus. 
 
The peptide libraries were also subjected to a panel of clinically relevant pathogens comprised of 
A. baumannii, K. pneumoniae and S. aureus. The bioactivity profiles of each plant species against all of the 
bacteria strains is compared to determine the fractions most likely containing antimicrobial peptides. As an 
example, the bioactivity profiles of chameleon plant against the three pathogens is shown in Figure 1 (b) 
(c) and (d). Looking at the information between fractions 10-35, one can observe an obvious region with 
strong activity around fractions 16-25 in Figure 2(b) and 19-26 in 2(c). In Figure 2(d), the high activity 
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level (all >20%) throughout later fractions makes the data relatively unreliable. Inappropriate operation or 
confounding environmental factors may have contributed to this outcome. However, the bioactivity in 
fractions 21-23 is still outstanding (>40%). Overall, the bioassay result of the four pathogens gives strong 
evidence that the core region for novel AMP discovery is located at fractions 16-26. There is also another 
trend at fractions 26-36 in Figure 2(b), yet its absence on other graphs shift the primary attention back to 
fractions 16-26. Subsequent mass spectrometry and statistical analysis will then match peptide abundance 
profiles determined by LC-MS/MS analysis with the “area of interest” from the bioactivity against each 
pathogen. 
 
MS Profiling, Data Reduction, and Statistical Modeling. To investigate the identity of the 
bioactive peptide—or possibly a cooperative group of peptides—that contributes to the antibacterial 
properties, a hybrid methodology of mass spectrometry, bioinformatic processing and statistical modeling 
is employed. With the accurate intact mass data as well as its relative intensity provided by nanoLC-
MS/MS, bioinformatics technology sorts the information to give 12,078 m/z levels. The binning function 
in PepSAVI-MS further consolidates the data based on parameters specifying mass, charge, and retention 
time, reporting 4,973 binned m/z levels. Filtering through the broad region of fractions 16-26, the package 
gives 98 candidate compounds that satisfy the following criteria: 1) m/z intensity maximum is in between 
fraction 16 and fraction 26; 2) this maximum intensity is  >1000; 3) its intensity levels at fraction 16 and 
26 are both <1% of the maximum peak intensity; 4) its intensity at the immediate neighboring fractions of 
the maximum peak is nonzero; 5) its charge state should be less than +10. Among the 98 candidates, the 
top 20 with the highest probability to contribute to the bioactivity against each pathogen—whether 
working individually or co-operationally—are ranked in order via sparse penalized linear regression 
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E.coli K. pneumoniae 
mtoz charge comp_cor 
neutral 
mass mtoz charge comp_cor 
neutral 
mass 
506.2833 3 0.83404 1515.828 567.2955 3 0.804789 1698.865 
773.3935 2 0.959949 1544.772 862.9348 2 0.77599 1723.855 
850.4425 2 0.806187 1698.87 597.3187 4 0.710025 2385.246 
916.9265 2 0.803311 1831.838 870.9459 2 0.777773 1739.877 
739.9566 3 0.856957 2216.848 505.9375 3 0.746256 1514.791 
866.9347 2 0.781195 1731.855 455.5822 3 0.016005 1363.725 
567.2955 3 0.868042 1698.865 866.9347 2 0.285535 1731.855 
870.9459 2 0.676075 1739.877 565.0607 4 0.651659 2256.214 
871.9406 2 0.752259 1741.867 858.9847 2 0.203331 1715.955 
862.9348 2 0.678298 1723.855 936.4491 2 0.204088 1870.884 
897.9285 2 0.634773 1793.842 673.3559 3 0.715504 2017.046 
877.9543 2 0.601349 1753.894 425.2404 3 0.538231 1272.699 
1180.607 2 0.601349 2359.2 753.0803 3 0.680537 2256.219 
606.0123 3 0.630923 1815.015 983.5191 5 0.676852 4912.559 
673.3559 3 0.705559 2017.046 1229.158 2 0.677328 2456.302 
858.9847 2 0.614905 1715.955 1129.117 2 0.634986 2256.22 
505.9375 3 0.722658 1514.791 739.9566 3 0.225652 2216.848 
656.7375 5 0.49457 3278.651 1193.639 2 0.679259 2385.263 
682.3572 3 0.612487 2044.05 537.7748 2 0.449377 1073.535 
892.4319 2 0.538897 1782.849 547.7845 2 0.468582 1093.554 
A. baumannii S. aureus 
mtoz charge comp_cor 
neutral 
mass mtoz charge comp_cor 
neutral 
mass 
405.2382 3 0.712488 1212.693 567.2955 3 0.780225 1698.865 
673.3559 3 0.552275 2017.046 983.5191 5 0.639149 4912.559 
455.5822 3 0.667301 1363.725 505.9375 3 0.764599 1514.791 
505.9375 3 0.493664 1514.791 597.3187 4 0.645405 2385.246 
390.2337 3 0.708775 1167.679 862.9348 2 0.702901 1723.855 
986.1829 3 0.706005 2955.527 1193.639 2 0.636163 2385.263 
519.0456 4 0.701244 2072.153 1229.158 2 0.635287 2456.302 
739.8923 4 0.701989 2955.54 506.2833 3 0.02905 1515.828 
745.3846 4 0.698724 2977.509 753.0803 3 0.631507 2256.219 
910.1516 3 0.692455 2727.433 1129.117 2 0.600239 2256.22 
567.2955 3 0.46284 1698.865 565.0607 4 0.603378 2256.214 
435.1282 6 0.447383 2604.726 737.9282 2 0.550909 1473.842 
579.7197 2 0.444654 1157.425 673.3559 3 0.72136 2017.046 
537.7748 2 0.43557 1073.535 547.7845 2 0.504573 1093.554 
702.3716 3 0.63005 2104.093 537.7748 2 0.484706 1073.535 
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Interestingly, the two candidates marked in blue are the ions of the same peptide identity 
(1698.87 Da) with different charge states. These two candidates are not only ranked at the tops of all four 
modeling results but also assigned high individual marginal correlations. The search for their abundance 
and structural information is thus prioritized.  
Characterizations. The two MS features, with m/z of 567.3 and 850.4, are most abundant in 
fraction 21 and 22, respectively (Figure 2). As the raw abundance of m/z=567.3 in fraction 22 is almost 
equally high as in fraction 21, the subsequent sequencing and isolation will mainly be using the MS and 
MS/MS data of fraction 22.   
Figure 2. Raw abundance of m/z [charge]= (a) 567.3 [3] and (b) 850.4 [2] across SCX fractions 11-40.  
(c) The combined raw abundance of both features with a neutral mass of 1698.87 across SCX fractions 
11-40. 
547.7845 2 0.433143 1093.554 425.2404 3 0.508636 1272.699 
850.4425 2 0.302941 1698.87 435.1282 6 0.495916 2604.726 
867.9281 4 0.44177 3467.683 579.7197 2 0.484727 1157.425 
870.9459 2 0.176857 1739.877 850.4425 2 0.656272 1698.87 
862.9348 2 0.156519 1723.855 606.0123 3 0.648583 1815.015 
Table 2  Statistical modeling results of the top 20 peptide candidates contributing to the bioactivity 
against each pathogen. The prioritized MS features with the same neutral mass are highlighted in blue. 
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 De novo Sequencing. The MS2 spectra of both features, undigested and under CID, were studied 
for peptide sequencing. As CID induces cleavage at amide bond, the peaks on MS2 spectra correspond to 
b ions (N-terminus fragments) and y ions (C-terminus fragments) of the precursor, peak differences equal 
to the masses of amino acids. The sequence of the peptide can thus be calculated by matching the b and y 
ions to the fragments in MS2. The PEAKS Studio software extracts MS2 spectra whose precursors all have 
a neutral mass in between 1698.85-1698.89 Da, and it gives the predicted sequence for each spectrum 
analyzed (Figure 3). The predicted sequences of our target peptide are highly consistent and all with high 
average local confidence (ALC).
 
Figure 3. PEAKS Studio predicted amino acid sequence of MS features with a specified neutral mass of 
1698.85 to 1698.89 Da. On each sample loaded into the software, the software gives the selected MS1 ion 
at "m/z" column and the predicted sequence based on the defined range of precursor neutral mass (error 
tolerance at 0.02 Da). Residues in red have a confidence level above 90%, purple 80-90%, blue 60-80% 
and black <60%. 
  
Conclusions and Future Directions  
 The peptide library of chameleon plant was created using acetic acid extraction and strong cation 
exchange chromatography. The downstream analysis of PepSAVI-MS has shown that this species contain 
peptides that can efficiently kill pathogens E. coli, A. baumannii, K. pneumoniae, and S. aureus. Eluting 
around fractions 18-23, the putative antimicrobial peptides were identified after the statistical modeling of 
bioassays and ion abundance. Among the ranks of putative peptides, one with a neutral mass of 1698.87 
Da and two charge states is highly likely to be the AMP causing the bioactivities. The purified sample of 
this peptide will be obtained using reversed-phase liquid chromatography. For further characterization, de 
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novo sequencing and multi-enzyme digestion coupled with mass spectrometry will be employed to 
investigate the structural details of the peptides. Once the compound is isolated, its activity against E.coli 
will be verified. The minimum inhibitory concentration against various pathogens will also be determined 
if the peptide shows bioactivity as expected.  
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